Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies. (Q51313042)
Jump to navigation
Jump to search
scientific article published on 8 November 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies. |
scientific article published on 8 November 2014 |
Statements
Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies. (English)
1 reference
Susan O'Brien
1 reference
John C Byrd
1 reference
Ranjana Advani
1 reference
Juthamas Sukbuntherng
1 reference
David Loury
1 reference
Eleonora Marostica
1 reference
Jan de Jong
1 reference
Xavier Woot de Trixhe
1 reference
An Vermeulen
1 reference
Giuseppe De Nicolao
1 reference
Jesse McGreivy
1 reference
Italo Poggesi
1 reference
8 November 2014
1 reference
75
1 reference
1
1 reference
111-121
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference